Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Drug Discov Today. 2018 Aug 3;23(12):1983–1989. doi: 10.1016/j.drudis.2018.08.001

FIGURE 3.

FIGURE 3

Lead optimization using in silico quantitative structure–activity relationship (QSAR) modeling, molecular docking, bioavailability, drug likeness, and toxicity parameters followed by wet lab synthesis and biological validation.